Elekta Versa HD™
12Pages

Elekta Versa HD Push the boundaries of your stereotactic capabilities

Stereotactic treatments demand the highest levels of accuracy, precision and efficiency. As evidence continues to grow for new SRS and SBRT indications, ensure you have the right platform to empower the treatments of tomorrow.

* Enable high definition dynamic radiosurgery (HDRS) • Provide stereotactic treatments with anatomically guided accuracy • Assure end-to-end confidence

Enable high definition dynamic radiosurgery (HDRS) Versa HD—our premium system-delivers absolute reliability, accuracy and confidence in stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) treatments, to help you grow your stereotactic program as a mainstream technique. Confidently treat complex or challenging cancers with submillimeter, end-to-end accuracy. Plan and deliver. • Monaco enables gold standard treatment planning with Monte Carlo accuracy • Fewer, single or partial arcs allow faster treatment delivery without compromising quality - Single or multiple...

Deliver highly conformal SRS/SBRT in standard treatment slots Treat smaller stereotactic targets HDRS full-field virtual leaf hypermodulation HexaPOD™ evo RT Fully integrated robotic positioning system with six degrees of freedom Elekta IntelliBeam Other Systems Flexible gantry rotation with up to 1,024 dynamic control points. Equidistant control point size up to 180 control points per arc. 2. Shorter delivery time 3. uperior plan quality S Comparison between Elekta linacs using Pinnacle, Raystation, and Elipse to a Versa HD system with Monaco Treat more patients, faster. · Versa HD...

Provide stereotactic treatments with anatomically guided accuracy The innovative imaging and motion management technology found in Versa HD gives clinicians the confidence to reduce margins and escalate dose to the target. It expands the scope of HDRS reaching smaller targets in locations previously untreatable with radiation.

Advanced 4D Image Guidance for lung and prostate SBRT Manage complex motion without implanted markers See more, treat more. · ersa HD offers 4D image-guided radiotherapy (IGRT) V · isualize very small and moving tumors V that can’t be seen with 3D imaging · scalate dose while safely reducing margins E · repare for the future by offering cost-effective P stereotaxy treatments as surgical alternatives Be accurate. · ersa HD assures submillimeter end-to-end accuracy V · ttain high-quality 2D, 3D and 4D intra-fraction imaging A Anatomically correlated 4D Image Guidance allows fiducial-free lung...

Assure end-to-end confidence Our end-to-end Versa HD methodology provides the highest levels of dose delivery accuracy allowing you to push the boundaries of clinical capabilities. Plan, Patient and Machine QA offer total system confidence. · onaco treatment planning with gold standard M Monte Carlo algorithm ensures what you plan is what you treat · In-vivo patient dosimetry compares the EPID-detected dose during treatment to the plan-predicted dose, and acts as a treatment safety net at time of treatment · QUA™ provides standardized automated QA A to streamline, centralize and simplify...

“The use of Monaco, with the rapid and accurate Monte Carlo dose calculation algorithm, together with the high available modulation that can be achieved using Monaco and Agility (where the mechanism of the MLC leaves and the dynamic jaws produce a 'virtual leaf width' of as little as 1 mm) allows highly accurate dose calculation, even for very small targets (~1.0 cc).” Lip Teck Chew, PhD, Chief Medical Physicist Farrer Park Hospital, Singapore with anatomically guided accuracy

"Advanced motion management technologies are critical to facilitate highly accurate and potent stereotactic radiation therapy for early stage, inoperable lung tumors. Versa HD integrates these and other solutions—such as 4D image guidance and sophisticated patient immobilization and treatment planning—into a specialized package for lung cancer. For the patient, it will mean a higher therapeutic dose of radiation to the lung tumor, with reduced exposure to nearby healthy tissues.” Vivek Mehta, MD, Director Center for Advanced Targeted Radiotherapies Swedish Cancer Institute, Seattle, WA...

For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to—and benefits from—more precise, personalized radiotherapy treatments. * f in elekta.com /elekta @elekta /company/ elekta LPCVHD190103 © 2019 Elekta AB (publ.) All mentioned trademarks and registered trademarks are the property of the Elekta Group. All rights reserved. No part of this document may be reproduced in any form without written permission from the copyright holder.